Cancún, Mexico — The International Society for Stem Cell Application (ISSCA) announces the ISSCA Global Summit 2026, taking place on September 11–12, 2026, in Cancún, Mexico. Recognized as the largest global event in regenerative medicine, the ISSCA Global Summit will bring together 20 international speakers and an expected audience of over 800 physicians and healthcare professionals from around the world.
Designed as ISSCA’s flagship global meeting, the Global Summit represents the convergence of Asia, Europe, the Americas, Africa, and the Middle East, uniting all continents around a shared objective: advancing regenerative medicine through science, education, collaboration, and international standards.
A Truly Global Platform for Regenerative Medicine
The ISSCA Global Summit is defined not only by its scale, but by its global reach and educational depth. The previous edition welcomed physicians from 32 different countries, creating one of the most internationally representative forums in the field of regenerative medicine.
Building on this foundation, the 2026 edition will expand both participation and academic scope, reinforcing ISSCA’s role as a global platform where clinicians, researchers, and innovators converge to shape the future of regenerative and precision medicine.
“The Global Summit reflects what ISSCA represents at its core: global collaboration,” said Benito Novas, Founder of ISSCA.
“When physicians from every continent come together to share knowledge, clinical experience, and vision, regenerative medicine advances not as a regional practice, but as a global medical discipline.”
Five Simultaneous Certifications: A Global Educational Milestone
One of the defining features of the ISSCA Global Summit 2026 is the delivery of five advanced international certifications taking place simultaneously, making this event the most comprehensive educational experience ever organized by ISSCA.
Physicians attending the Global Summit will have access to structured certification pathways across multiple clinical disciplines, including:
- Mastering Next-Generation Cellular Therapies and Regenerative Medicine Certification
- Sport & Musculoskeletal Repair Certification
- Advanced Peptide Certification
- Advanced Regenerative Aesthetics Certification
- MUSE Cells Technology Certification
This multi-certification format reflects ISSCA’s commitment to offering specialized, evidence-based education that aligns with the diverse realities of modern medical practice, allowing physicians to pursue targeted training while participating in a global scientific forum.
International Faculty and Scientific Leadership
ISSCA Global Summit 2026 will feature 20 internationally recognized speakers, representing diverse medical systems, regulatory environments, and clinical perspectives. This diversity fosters a richer scientific dialogue and a more comprehensive understanding of how regenerative medicine is being applied across the world.
The scientific program will address key areas shaping the future of the field, including:
- Regenerative and cellular therapies
- Peptide-based medicine and signaling pathways
- Exosomes and next-generation biologics
- Musculoskeletal (MSK) regeneration and repair
- Longevity, metabolic health, and inflammation control
- Ethical practice, clinical responsibility, and patient safety
- Emerging technologies influencing regenerative medicine
Beyond a Conference: A Global Medical Convergence
The ISSCA Global Summit extends beyond lectures and certifications. Designed as a global convergence point, the event creates curated environments where physicians, faculty, and industry leaders can exchange ideas, establish strategic alliances, and build long-term professional relationships.
These interactions are a cornerstone of ISSCA’s mission—to foster a global regenerative medicine community grounded in collaboration, responsibility, and shared standards of excellence.
“Coordinating an event of this magnitude requires more than logistics—it requires a shared vision,” said Yamile Noriega, Director of Operations at ISSCA.
“The Global Summit brings together multiple disciplines, cultures, and continents into one cohesive educational experience, reflecting the scale and maturity of regenerative medicine worldwide.”
Cancún as a Strategic Global Host
Cancún’s international connectivity and infrastructure make it an ideal host city for a summit of this scale. Its accessibility for attendees from Europe, the Americas, Asia, and beyond reinforces the Global Summit’s mission of inclusivity and global participation.
The location supports ISSCA’s objective of making high-level regenerative medicine education accessible to physicians worldwide, while providing an environment conducive to learning, collaboration, and global exchange.
Setting the Global Standard for Regenerative Medicine
ISSCA Global Summit 2026 is more than an annual meeting—it is a benchmark. By convening hundreds of physicians from across the world, hosting internationally respected faculty, and delivering five simultaneous certification programs, ISSCA continues to set the global standard for education and collaboration in regenerative medicine.
The 2026 edition is expected to be the largest and most internationally diverse regenerative medicine event ever organized, reinforcing ISSCA’s leadership at the forefront of the field.
Physicians and healthcare professionals interested in attending the ISSCA Global Summit 2026 (September 11–12) can register at:
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.
About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business, partly based on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
